10-Q: Diversified Healthcare Trust Q3 2025: Mixed Results Amid Strategic Shifts

Diversified Healthcare Trust reports a net loss of $164.0 million for Q3 2025, alongside strategic property dispositions and management transitions in its senior living portfolio.

Summary

• Net loss for the three months ended September 30, 2025, was $(164,040) thousand, compared to $(98,689) thousand for the same period in 2024.
• Net loss for the nine months ended September 30, 2025, was $(264,665) thousand, an improvement from $(282,809) thousand for the same period in 2024.
• Total revenues for Q3 2025 increased to $388,706 thousand from $373,640 thousand in Q3 2024.
• Total revenues for the nine months ended September 30, 2025, increased to $1,158,282 thousand from $1,115,808 thousand in the same period in 2024.
• Impairment of assets significantly increased to $93,243 thousand in Q3 2025 from $23,031 thousand in Q3 2024.
• A gain on sale of properties of $103,971 thousand was recognized for the nine months ended September 30, 2025, compared to a loss of $(18,976) thousand in the prior year period.
• A loss on modification or early extinguishment of debt of $(11,191) thousand was recorded in Q3 2025 and $(40,388) thousand for the nine months ended September 30, 2025.
• The SHOP segment's Net Operating Income (NOI) increased by 8.0% for Q3 2025 and 27.0% for the nine months ended September 30, 2025.
• The Medical Office and Life Science Portfolio segment's NOI decreased by 4.1% for Q3 2025 and 9.4% for the nine months ended September 30, 2025.
• Occupancy in the SHOP segment improved to 81.5% in Q3 2025 from 79.4% in Q3 2024.
• Occupancy in the Medical Office and Life Science Portfolio increased to 86.6% in Q3 2025 from 80.8% in Q3 2024.
• As of November 3, 2025, management agreements for 85 senior living communities had been transitioned from Five Star to new and existing managers, with remaining transitions expected by December 31, 2025.
• Sold 32 properties for an aggregate sales price of $353,675 thousand during the nine months ended September 30, 2025.
• Subsequent to September 30, 2025, sold an additional 12 properties for an aggregate sales price of $42,130 thousand.
• As of November 3, 2025, 38 properties were under agreements or letters of intent to sell for an aggregate sales price of $237,219 thousand.
• Issued $375,000 thousand in 7.25% senior secured notes due 2030 in September 2025, using net proceeds to partially redeem senior secured notes due 2026.
• Fully redeemed the remaining $380,000 thousand of 9.75% senior unsecured notes due June 2025 using proceeds from new mortgage financings and cash on hand.
• Obtained a new $150,000 thousand revolving credit facility in June 2025, with no borrowings outstanding as of September 30, 2025, and November 3, 2025.
• Credit ratings were upgraded by Moody's in August 2025 and S&P Global in September 2025.

Sentiment

Score: 4

Explanation: The company is undergoing significant strategic restructuring, including extensive property dispositions and management transitions, which are creating short-term financial volatility, as evidenced by the increased net loss and substantial impairment charges. While there are positive operational trends in the SHOP segment (occupancy, rates, NOI growth) and successful debt refinancing efforts, the Medical Office and Life Science segment shows declining NOI. The credit rating upgrades are a positive signal for debt management, but the overall financial performance is weak due to the large losses and impairments.

Positives

• Total revenues increased for both the three months ($388,706 thousand) and nine months ($1,158,282 thousand) ended September 30, 2025, compared to the prior year periods.
• Recognized a significant gain on sale of properties of $103,971 thousand for the nine months ended September 30, 2025, a substantial improvement from a loss in the prior year.
• The SHOP segment showed strong operational improvement with NOI increasing by 8.0% for Q3 2025 and 27.0% for the nine months ended September 30, 2025.
• Occupancy rates improved in both the SHOP segment (81.5% in Q3 2025 vs. 79.4% in Q3 2024) and the Medical Office and Life Science Portfolio (86.6% in Q3 2025 vs. 80.8% in Q3 2024).
• Successfully managed debt maturities by fully redeeming $380,000 thousand of 9.75% senior unsecured notes due June 2025 and partially redeeming senior secured notes due 2026.
• Issued $375,000 thousand in new 7.25% senior secured notes due 2030, demonstrating access to capital markets.
• Secured a new $150,000 thousand revolving credit facility, enhancing liquidity with no current borrowings.
• Received credit rating upgrades from Moody's and S&P Global in August and September 2025, respectively, indicating improved creditworthiness.
• Recognized a gain on insurance recoveries of $7,522 thousand for the nine months ended September 30, 2025.

Negatives

• Net loss for Q3 2025 significantly increased to $(164,040) thousand from $(98,689) thousand in Q3 2024.
• Recorded substantial impairment charges of $93,243 thousand in Q3 2025 and $162,708 thousand for the nine months ended September 30, 2025, reflecting asset value write-downs.
• The Medical Office and Life Science Portfolio segment experienced a decrease in NOI of 4.1% for Q3 2025 and 9.4% for the nine months ended September 30, 2025.
• Incurred a loss on modification or early extinguishment of debt of $11,191 thousand in Q3 2025 and $40,388 thousand for the nine months ended September 30, 2025.
• General and administrative expenses increased for the nine months ended September 30, 2025, primarily due to higher estimated incentive management fees.
• Property operating expenses in the SHOP segment increased due to higher labor costs, marketing, and contract labor.
• Cash provided by operating activities decreased for the nine months ended September 30, 2025, primarily due to the payment of accreted interest on senior secured notes.

Risks

• Unfavorable market and commercial real estate industry conditions, including reduced demand for healthcare-related space and senior living communities.
• Uncertainties surrounding interest rates, wage and commodity price inflation, and supply chain disruptions.
• Volatility in public debt and equity markets, and global geopolitical instability.
• Labor market conditions and changes in real estate utilization.
• Senior living operators' abilities to successfully and profitably operate the communities.
• Delayed recovery of the senior housing industry and reduced demand for leased medical office, life science, and other space.
• Increased operating costs, particularly for labor, insurance, and food.
• Financial strength of managers, operators, and tenants.
• Temporary disruption and reductions in cash flows during the transition of senior living community management.
• Uncertainty regarding tenant lease renewals or obtaining replacement tenants on favorable terms.
• Risk that tenants and residents may not pay rent or be negatively impacted by continuing unfavorable market conditions.
• Risks and uncertainties regarding the costs and timing of development, redevelopment, and repositioning activities, including inflation, cost overruns, and construction delays.
• Ability to effectively raise and balance the use of debt and equity capital.
• Ability to comply with financial covenants under debt agreements.
• Ability to make required payments on debt and maintain sufficient liquidity.
• Impact of credit ratings on financing costs and availability.
• Ability to sell properties at targeted prices or returns, and the timing of such sales.
• Non-performance by counterparties to interest rate caps.
• Actual and potential conflicts of interest with related parties, including RMR, ABP Trust, and AlerisLife.
• Limitations imposed by and ability to satisfy complex rules to maintain REIT qualification for U.S. federal income tax purposes.

Future Outlook

The company expects continued variability in labor, insurance, and food costs in its SHOP segment but anticipates moderation, which should allow managers to increase rates in excess of costs, leading to improving returns. Favorable supply and demand dynamics in the senior living industry are expected to drive continued occupancy growth and positive performance. The company plans to continue investing capital in properties, including redevelopment projects, to enhance future returns, funding these through operating cash flows, cash on hand, property dispositions, and future financing activities. Redevelopment projects may be deferred to preserve liquidity due to labor and inflation constraints. The company believes its current funding sources will be sufficient for operating and capital expenses, debt service, and distributions for at least the next 12 months and the foreseeable future.

Management Comments

• "We are encouraged by positive trends, including increases in rates, margins and occupancy, in our SHOP segment."
• "Additionally, we expect that favorable supply and demand dynamics in the senior living industry will enable our managers to continue to grow occupancy and drive positive performance."
• "While certain costs, primarily labor, insurance and food costs, have increased, we expect these cost increases to moderate, which will provide our managers the opportunity to increase rates in excess of increases in costs, resulting in improving returns to us."
• "Our strategy to drive positive performance includes analyzing non-performing communities for potential disposition or transition to different operators."
• "We are closely monitoring the impacts of the current economic and market conditions on all aspects of our business, including, but not limited to, uncertainties surrounding interest rates and inflation, volatility in the public debt and equity markets, global geopolitical hostilities and tensions, any U.S. government shutdown, economic uncertainties and tariffs, labor market conditions and changes in real estate utilization."
• "We believe we were in compliance with the terms and conditions of our debt agreements as of September 30, 2025."
• "We believe we may have access to various types of financings, including debt or equity offerings, to fund our operations and repay our debts and other obligations as they become due."

Industry Context

The company operates within the healthcare real estate sector, focusing on senior living and medical office/life science properties. It acknowledges industry-wide challenges such as rising labor, insurance, and food costs, alongside broader economic uncertainties like inflation and high interest rates impacting the commercial real estate market. The strategic transition of senior living community management from Five Star to multiple third-party managers reflects an industry trend towards optimizing operational efficiency. The company notes favorable supply and demand dynamics in the senior living industry, driven by an aging U.S. population, as a positive long-term trend.

Comparison to Industry Standards

• The company uses the MSCI U.S. REIT/Health Care REIT Index as a benchmark for calculating incentive management fees, comparing its common share total return against this specific industry index.

Corporate Governance

Related Party Transactions

• Maintains relationships and historical and continuing transactions with RMR, RMR Inc., AlerisLife (including Five Star), and others related to them.
• ABP Trust and Adam Portnoy owned 9.8% of outstanding common shares as of September 30, 2025.
• Acquired approximately 34.0% of AlerisLife common shares from ABP Trust for $15,459 thousand on February 16, 2024.
• Received cash dividends from AlerisLife of $17,000 thousand (February 14, 2025) and $3,400 thousand (July 15, 2025) as its pro rata share.
• RMR provides management services to the company and its joint ventures (Seaport JV and LSMD JV).
• Accrued estimated incentive management fees to RMR of $5,676 thousand for Q3 2025 and $12,231 thousand for 9M 2025.
• Paid business management fees to RMR of $3,967 thousand for Q3 2025 and $11,517 thousand for 9M 2025.
• Paid property management fees to RMR of $1,199 thousand for Q3 2025 and $3,643 thousand for 9M 2025.
• Paid construction supervision fees to RMR of $341 thousand for Q3 2025 and $775 thousand for 9M 2025.
• Reimbursed RMR for property level expenses of $3,085 thousand for Q3 2025 and $10,144 thousand for 9M 2025.
• Reimbursed RMR for other expenses of $50 thousand for Q3 2025 and $150 thousand for 9M 2025.
• Leases office space to RMR, recognizing rental income of $102 thousand for Q3 2025 and $311 thousand for 9M 2025.
• Consented to RMR's pledge of its interest in the company's management agreements to Citibank, N.A., under specific conditions.

Stakeholder Impact

• Shareholders: Experienced increased net loss and significant impairment charges, negatively impacting equity. Quarterly distributions of $0.01 per share were maintained. Credit rating upgrades could positively influence investor confidence.
• Employees: Management transitions for 116 senior living communities from Five Star to new managers may impact employees at those communities.
• Customers (Residents/Tenants): Increased occupancy and average monthly rates in the SHOP segment suggest continued demand. Vacancies in the Medical Office and Life Science Portfolio indicate some tenant turnover.
• Creditors: Successful debt redemptions and new financings, along with credit rating upgrades, improve the company's debt profile and reduce immediate refinancing risk, though significant debt maturities remain.
• Managers/Operators: Five Star is winding down its business, leading to management transitions. New third-party managers are taking over. RMR continues to provide management services, with its agreements now subject to Citibank's oversight.

Next Steps

• Complete management transitions for the remaining senior living communities by December 31, 2025.
• Continue investing capital in properties, including redevelopment projects, to increase future returns.
• Fund estimated unspent leasing related obligations of approximately $20,405 thousand during the next 12 months.
• Monitor and potentially defer certain redevelopment projects to preserve liquidity.
• Potentially exercise the one-time option to extend the maturity date of senior secured notes due 2026 by one year to January 15, 2027.
• Continue efforts to sell properties, with 38 properties currently under agreements or letters of intent to sell for $237,219 thousand.
• Pay a quarterly distribution of $0.01 per share on or about November 13, 2025.
• Evaluate the impact of ASU 2024-03 on condensed consolidated financial statements.

Key Dates

Recommendation

The company is navigating a complex period of strategic restructuring, marked by substantial asset dispositions and management transitions in its senior living portfolio. While there are positive operational trends in the SHOP segment, including improved occupancy and NOI, the overall financial performance is challenged by a significant increase in net loss and substantial impairment charges. Successful debt refinancing and credit rating upgrades are positive for financial stability. However, ongoing economic uncertainties, the execution risk associated with property sales, and the potential for disruption during management transitions warrant a cautious 'hold' stance. Investors should monitor the successful completion of these strategic initiatives and the stabilization of financial performance across all segments.

Keywords

Healthcare REIT, Senior Living, Medical Office, Life Science, Real Estate, Property Management, Debt Refinancing, Asset Sales, Occupancy Rates, Net Operating Income, SEC Filing, DHC, AlerisLife, RMR